Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q3 2019 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2019-11-13

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 13, 2019

Total Value: $309M (100.0% shares, 0.0% debt)

Holdings (19)

— Turning Point Therapeutics, Inc. 22.2%

Value $68.67M Shares 1,826,374 Est. Cost $40.70 Unrealized —

— Aerie Pharmaceuticals, Inc. 8.7%

Value $26.93M Shares 1,400,900 Est. Cost $24.63 Unrealized —

INSM Insmed Incorporated 8.1%

Value $25.22M Shares 1,429,518 Est. Cost $26.85 Unrealized -28.1%

— The Medicines Company 7.7%

Value $23.91M Shares 478,217 Est. Cost $42.94 Unrealized —

ASND Ascendis Pharma A/S 7.6%

Value $23.64M Shares 245,424 Est. Cost $40.06 Unrealized —

CYTK Cytokinetics Incorporated 7.0%

Value $21.61M Shares 1,898,970 Est. Cost $7.56 Unrealized +66.0%

— Biohaven Pharmaceutical Holding Company Ltd. 5.7%

Value $17.76M Shares 425,794 Est. Cost $26.07 Unrealized —

— OptiNose, Inc. 5.1%

Value $15.67M Shares 2,238,006 Est. Cost $15.00 Unrealized —

VYGR Voyager Therapeutics, Inc. 4.6%

Value $14.29M Shares 830,565 Est. Cost $21.95 Unrealized —

ALEC Alector, Inc. 4.4%

Value $13.5M Shares 936,371 Est. Cost $18.92 Unrealized -4.6%

— Myokardia, Inc. 4.0%

Value $12.42M Shares 238,186 Est. Cost $45.40 Unrealized —

FULC Fulcrum Therapeutics, Inc. 3.6%

Value $11.21M Shares 1,687,500 Est. Cost $11.06 Unrealized 0.0%

— CymaBay Therapeutics, Inc. 3.4%

Value $10.55M Shares 2,060,268 Est. Cost $8.89 Unrealized —

— Orchard Therapeutics PLC 2.1%

Value $6.625M Shares 557,700 Est. Cost $11.88 Unrealized —

RYTM Rhythm Pharmaceuticals, Inc. 1.6%

Value $5.062M Shares 234,482 Est. Cost $26.85 Unrealized -20.1%

— Immunomedics, Inc. 1.6%

Value $4.875M Shares 367,636 Est. Cost $17.13 Unrealized —

SIBN SI-BONE, Inc. 1.2%

Value $3.633M Shares 205,621 Est. Cost $18.92 Unrealized +1.2%

— Aerie Pharmaceuticals, Inc. 0.6%

Value $1.932M Shares 100,500 Est. Cost $24.63 Unrealized —

— Aerie Pharmaceuticals, Inc. 0.6%

Value $1.932M Shares 100,500 Est. Cost $24.63 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Turning Point Therapeutics, Inc.	1,826,374	$68.67M	22.2%	$40.70	—	COM	90041T108
—	Aerie Pharmaceuticals, Inc.	1,400,900	$26.93M	8.7%	$24.63	—	COM	00771V108
INSM	Insmed Incorporated	1,429,518	$25.22M	8.1%	$26.85	-28.1%	COM	457669307
—	The Medicines Company	478,217	$23.91M	7.7%	$42.94	—	COM	584688105
ASND	Ascendis Pharma A/S	245,424	$23.64M	7.6%	$40.06	—	SPONSORED ADR	04351P101
CYTK	Cytokinetics Incorporated	1,898,970	$21.61M	7.0%	$7.56	+66.0%	COM NEW	23282W605
—	Biohaven Pharmaceutical Holding Company Ltd.	425,794	$17.76M	5.7%	$26.07	—	COM	G11196105
—	OptiNose, Inc.	2,238,006	$15.67M	5.1%	$15.00	—	COM	68404V100
VYGR	Voyager Therapeutics, Inc.	830,565	$14.29M	4.6%	$21.95	—	COM	92915B106
ALEC	Alector, Inc.	936,371	$13.5M	4.4%	$18.92	-4.6%	COM	014442107
—	Myokardia, Inc.	238,186	$12.42M	4.0%	$45.40	—	COM	62857M105
FULC	Fulcrum Therapeutics, Inc.	1,687,500	$11.21M	3.6%	$11.06	0.0%	COM	359616109
—	CymaBay Therapeutics, Inc.	2,060,268	$10.55M	3.4%	$8.89	—	COM	23257D103
—	Orchard Therapeutics PLC	557,700	$6.625M	2.1%	$11.88	—	ADS	68570P101
RYTM	Rhythm Pharmaceuticals, Inc.	234,482	$5.062M	1.6%	$26.85	-20.1%	COM	76243J105
—	Immunomedics, Inc.	367,636	$4.875M	1.6%	$17.13	—	COM	452907108
SIBN	SI-BONE, Inc.	205,621	$3.633M	1.2%	$18.92	+1.2%	COM	825704109
—	Aerie Pharmaceuticals, Inc.	100,500	$1.932M	0.6%	$24.63	—	Put	00771V108
—	Aerie Pharmaceuticals, Inc.	100,500	$1.932M	0.6%	$24.63	—	Call	00771V108